UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice

Diabetologia, 2010-01, Vol.53 (1), p.192-203

2010

Volltextzugriff (PDF)

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes

Diabetologia, 2013-05, Vol.56 (5), p.1155-1165

2013

Volltextzugriff (PDF)

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice

Diabetologia, 2011-03, Vol.54 (3), p.681-689

2011

Volltextzugriff (PDF)

Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes

Diabetologia, 2012-05, Vol.55 (5), p.1544-1553

2012

Volltextzugriff (PDF)

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe−/− mice

Diabetologia, 2014-03, Vol.57 (3), p.633-642

2014

Volltextzugriff (PDF)

Insulin and cardiovascular disease: biomarker or association?

Diabetologia, 2012-12, Vol.55 (12), p.3145-3151

2012

Volltextzugriff (PDF)

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

Diabetologia, 2010-03, Vol.53 (3), p.584-592

2010

Volltextzugriff (PDF)

Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes

Diabetes care, 2020-09, Vol.43 (9), p.2161-2168

2020

Volltextzugriff (PDF)

Beyond Glycosuria: Exploring the intrarenal effects of SGLT-2 inhibition in diabetes

Diabetes & metabolism, 2014-12, Vol.40 (6), p.S17-S22

2014

Volltextzugriff (PDF)

HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

Diabetologia, 2008-09, Vol.51 (9), p.1731-1740

2008

Volltextzugriff (PDF)

Insulin and cardiovascular disease: biomarker or association?

Diabetologia, 2012-12, Vol.55 (12), p.3145-3151

2012

Volltextzugriff (PDF)

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes

PPAR Research, 2012-01, Vol.2012 (2012), p.338-347

2012

Volltextzugriff (PDF)

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation

Diabetologia, 2006-04, Vol.49 (4), p.766-774

2006

Volltextzugriff (PDF)

Linking RAGE and Nox in diabetic micro- and macrovascular complications

Diabetes & metabolism, 2015-09, Vol.41 (4), p.272-281

2015

Volltextzugriff (PDF)

Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus

Journal of hepatology, 2021-05, Vol.74 (5), p.1028-1037

2021

Volltextzugriff (PDF)

Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis

Diabetologia, 2010, Vol.53 (1), p.170-179

2010

Volltextzugriff (PDF)

Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules

Atherosclerosis, 2008-07, Vol.199 (1), p.55-64

2008

Volltextzugriff (PDF)

Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes

Diabetic medicine, 2011-01, Vol.28 (1), p.54-60

2011

Volltextzugriff (PDF)

Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease

Diabetologia, 2007-06, Vol.50 (6), p.1315-1326

2007

Volltextzugriff (PDF)

Nox4-mediated ROS production is involved, but not essential for TGFβ-induced lens EMT leading to cataract

Experimental eye research, 2020-03, Vol.192, p.107918-107918, Article 107918

2020

Volltextzugriff (PDF)

Dual ACE NEP inhibitors - more than playing the ACE card

Journal of human hypertension, 2006-07, Vol.20 (7), p.478-481

Jandeleit-Dahm, K A M

2006

Volltextzugriff (PDF)

Socio‐economic inequalities in glycaemic control in recently diagnosed adults with type 1 and type 2 diabetes

Diabetic medicine, 2022-07, Vol.39 (7), p.e14833-n/a

2022

Volltextzugriff (PDF)

Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes

Diabetologia, 2012-12, Vol.55 (12), p.3369-3381

2012

Volltextzugriff (PDF)

PPARs and diabetes-associated atherosclerosis

Current pharmaceutical design, 2007-09, Vol.13 (26), p.2736-2741

2007

Volltextzugriff (PDF)

Impact of mixed meal tolerance test composition on measures of beta-cell function in type 2 diabetes

Nutrition & metabolism, 2021-05, Vol.18 (1), p.47-47, Article 47

2021

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Englisch
(140)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(77)
Animals
(56)
Male
(48)
Diabetes
(47)
Biological And Medical Sciences
(42)
Medical Sciences
(41)
Humans
(39)
Endocrinology & Metabolism
(33)
Atherosclerosis
(26)
Mice
(26)
Diabetes Mellitus
(24)
Diabetes. Impaired Glucose Tolerance
(23)
Endocrine Pancreas. Apud Cells
(23)
Endocrinopathies
(23)
Cardiology. Vascular System
(20)
Cardiovascular System & Cardiology
(20)
Rats
(20)
Blood And Lymphatic Vessels
(17)
Mice, Knockout
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice

Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe−/− mice

Insulin and cardiovascular disease: biomarker or association?

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes

Beyond Glycosuria: Exploring the intrarenal effects of SGLT-2 inhibition in diabetes

HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

Insulin and cardiovascular disease: biomarker or association?

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation

Linking RAGE and Nox in diabetic micro- and macrovascular complications

Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus

Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis

Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules

Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes

Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease

Nox4-mediated ROS production is involved, but not essential for TGFβ-induced lens EMT leading to cataract

Dual ACE NEP inhibitors - more than playing the ACE card

Socio‐economic inequalities in glycaemic control in recently diagnosed adults with type 1 and type 2 diabetes

Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes

PPARs and diabetes-associated atherosclerosis

Impact of mixed meal tolerance test composition on measures of beta-cell function in type 2 diabetes

Suchergebnisse filtern